{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:30:08Z","timestamp":1791304208860,"version":"4.3.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:00:00Z","timestamp":1429747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003684","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T20:21:57Z","timestamp":1429820517000},"page":"e0003684","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["A Small Antigenic Determinant of the Chikungunya Virus E2 Protein Is Sufficient to Induce Neutralizing Antibodies which Are Partially Protective in Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Christopher","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"B\u00fcchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Schnierle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,23]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro2368","article-title":"Biology and pathogenesis of chikungunya virus","volume":"8","author":"O Schwartz","year":"2010","journal-title":"Nat.Rev.Microbiol"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2009.07.024","article-title":"Replication cycle of chikungunya: a re-emerging arbovirus","volume":"393","author":"M Solignat","year":"2009","journal-title":"Virology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1476-072X-12-51","article-title":"Climate change effects on Chikungunya transmission in Europe: geospatial analysis of vector's climatic suitability and virus' temperature requirements","volume":"12","author":"D Fischer","year":"2013","journal-title":"Int J Health Geogr"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/AEM.23.5.951-952.1972","article-title":"Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures","volume":"23","author":"A White","year":"1972","journal-title":"Appl.Microbiol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","article-title":"Development of an attenuated strain of chikungunya virus for use in vaccine production","volume":"4","author":"NH Levitt","year":"1986","journal-title":"Vaccine"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1128\/JVI.06449-11","article-title":"Attenuation of Chikungunya virus vaccine strain 181\/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein","volume":"86","author":"R Gorchakov","year":"2012","journal-title":"J.Virol"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"e1002142","DOI":"10.1371\/journal.ppat.1002142","article-title":"Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism","volume":"7","author":"K Plante","year":"2011","journal-title":"PLoS.Pathog"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4269\/ajtmh.2011.11-0049","article-title":"Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus","volume":"84","author":"JR Darwin","year":"2011","journal-title":"Am.J.Trop.Med.Hyg"},{"issue":"39","key":"ref9","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2008.07.054","article-title":"Chimeric alphavirus vaccine candidates for chikungunya","volume":"26","author":"E Wang","year":"2008","journal-title":"Vaccine"},{"issue":"40","key":"ref10","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"K Muthumani","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection","volume":"16","author":"W Akahata","year":"2010","journal-title":"Nat.Med"},{"issue":"36","key":"ref12","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2013.05.086","article-title":"A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus","volume":"31","author":"S Brandler","year":"2013","journal-title":"Vaccine"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.4049\/jimmunol.1300304","article-title":"An essential role of antibodies in the control of Chikungunya virus infection","volume":"190","author":"FM Lum","year":"2013","journal-title":"J.Immunol"},{"issue":"43","key":"ref14","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus","volume":"30","author":"M Kumar","year":"2012","journal-title":"Vaccine"},{"issue":"7324","key":"ref15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"JE Voss","year":"2010","journal-title":"Nature"},{"issue":"7324","key":"ref16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature09546","article-title":"Structural changes of envelope proteins during alphavirus fusion","volume":"468","author":"L Li","year":"2010","journal-title":"Nature"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/emmm.201200213","article-title":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","volume":"4","author":"YW Kam","year":"2012","journal-title":"EMBO Mol.Med"},{"issue":"0166\u20130934 (Linking)","key":"ref18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2014.02.001","article-title":"A neutralization assay for chikungunya virus infections in a multiplex format","volume":"201","author":"C Weber","year":"2014","journal-title":"J.Virol.Methods"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3201\/eid1503.081104","article-title":"Coordinated implementation of chikungunya virus reverse transcription-PCR","volume":"15","author":"M Panning","year":"2009","journal-title":"Emerg.Infect.Dis"},{"issue":"1742\u20134690 (Linking)","key":"ref20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-4690-8-21","article-title":"Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites","volume":"8","author":"B Kraus","year":"2011","journal-title":"Retrovirology"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2144\/03344bm02","article-title":"Improved host range selection for recombinant modified vaccinia virus Ankara","volume":"34","author":"C Staib","year":"2003","journal-title":"Biotechniques"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2010.05.008","article-title":"Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells","volume":"404","author":"J Zwilling","year":"2010","journal-title":"Virology"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"e72756","DOI":"10.1371\/journal.pone.0072756","article-title":"Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System","volume":"8","author":"B Kraus","year":"2013","journal-title":"PLoS.ONE"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00018-005-5548-7","article-title":"The translocation motif of hepatitis B virus improves protein vaccination","volume":"63","author":"E Bleifuss","year":"2006","journal-title":"Cell Mol.Life Sci"},{"issue":"7324","key":"ref25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"JE Voss","year":"2010","journal-title":"Nature"},{"key":"ref26","first-page":"77","article-title":"Construction and isolation of recombinant MVA","volume":"269","author":"C Staib","year":"2004","journal-title":"Methods Mol Biol"},{"issue":"39","key":"ref27","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2008.07.054","article-title":"Chimeric alphavirus vaccine candidates for chikungunya","volume":"26","author":"E Wang","year":"2008","journal-title":"Vaccine"},{"issue":"43","key":"ref28","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus","volume":"30","author":"M Kumar","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/600381","article-title":"Prophylaxis and therapy for Chikungunya virus infection","volume":"200","author":"T Couderc","year":"2009","journal-title":"J.Infect.Dis"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virusres.2012.05.004","article-title":"Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1\/Th2 response and virus-neutralizing antibodies in mice","volume":"167","author":"M Khan","year":"2012","journal-title":"Virus Res"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/156652308784049363","article-title":"The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer","volume":"8","author":"CE Gomez","year":"2008","journal-title":"Curr.Gene Ther"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine","volume":"74","author":"JC Ramirez","year":"2000","journal-title":"J.Virol"},{"issue":"1\u20133","key":"ref33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12026-012-8266-x","article-title":"Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology","volume":"53","author":"TH Teo","year":"2012","journal-title":"Immunol.Res"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"e2970","DOI":"10.1371\/journal.pntd.0002970","article-title":"A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice","volume":"8","author":"J Weger-Lucarelli","year":"2014","journal-title":"PLoS neglected tropical diseases"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1128\/JVI.03418-13","article-title":"A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection","volume":"88","author":"J Garcia-Arriaza","year":"2014","journal-title":"Journal of Virology"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"e3101","DOI":"10.1371\/journal.pntd.0003101","article-title":"Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge","volume":"8","author":"Petra van den Doel","year":"2014","journal-title":"PLoS neglected tropical diseases"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T07:35:08Z","timestamp":1598945708000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003684"}},"subtitle":[],"editor":[{"given":"Maya","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,23]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003684","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,23]]}}}